Apellis Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.

CEO

Cedric Francois

CEOCedric Francois

Employees

710

Employees710

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2009

Founded2009

Employees

710

Employees710

APLS Key Statistics

Market cap

3.76B

Market cap3.76B

Price-Earnings ratio

-15.44

Price-Earnings ratio-15.44

Dividend yield

—

Dividend yield—

Average volume

2.25M

Average volume2.25M

High today

$29.92

High today$29.92

Low today

$28.22

Low today$28.22

Open price

$28.22

Open price$28.22

Volume

2.46M

Volume2.46M

52 Week high

$35.72

52 Week high$35.72

52 Week low

$16.10

52 Week low$16.10

APLS News

TipRanks 2h

Apellis Pharmaceuticals’ Phase 4 Study Update: Real-World Insights on Pegcetacoplan

Apellis Pharmaceuticals ((APLS)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 5...

Analyst ratings

63%

of 19 ratings

Buy

63.2%

Hold

31.6%

Sell

5.3%

People also own

Based on the portfolios of people who own APLS. This list is generated using Robinhood data, and it’s not a recommendation.